Voluntary HIV counseling and testing of pregnant women - An assessment of compliance with Michigan public health statutes

MedGenMed Medscape General Medicine

Volumn 6, Issue 2, 2004, Pages

  Schuman, Paula ^a   Jones, Theodore B ^b   Ohmit, Suzanne ^c   Marbury, Cynthia ^c   Laken, Marilyn P ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR; CLINICAL PRACTICE; DEMOGRAPHY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH PROMOTION; HEALTH SURVEY; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFORMED CONSENT; INTERVIEW; MAJOR CLINICAL STUDY; MANDATORY TESTING; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MEDICAL RECORD; OBSTETRICS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PREGNANCY; PREGNANT WOMAN; PRENATAL SCREENING; PRIVATE PRACTICE; PUBLIC HEALTH SERVICE; PUERPERIUM; REFUSAL TO PARTICIPATE; RISK ASSESSMENT; SOCIAL ASPECT; UNITED STATES; URBAN AREA; VIRUS TRANSMISSION; DIRECTIVE COUNSELING; EVALUATION; LEGAL ASPECT; PRACTICE GUIDELINE; PUBLIC HEALTH; SERODIAGNOSIS;

ADOLESCENT; ADULT; AIDS SERODIAGNOSIS; DIRECTIVE COUNSELING; FEMALE; GUIDELINE ADHERENCE; HUMANS; MICHIGAN; PREGNANCY; PUBLIC HEALTH;

EID: 22044433776     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Connor EM, Spiraling RS, Gerber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
2. Newshan G, Hoyt MJ. Use of combination antiretroviral therapy in pregnant women with HIV disease. Am J Maternal Child Nurs. 1998;23:307-312.
3. Minkoff HL. Human immunodeficiency virus infection in pregnancy. Semin Perinatol. 1998;22:293-308.
4. Centers for Disease Control and Prevention. Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep. 1998;47:1-30.
5. Centers for Disease Control and Prevention. US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep. 1995;44:1-15.
6. Stoto MA, Almario DA, McCormick MC, eds. Reducing the Odds: Preventing Perinatal Transmission of HIV in the United States. Washington, DC: Institute of Medicine, National Academy Press; 1999.
7. Centers for Disease Control and Prevention. Success in implementing public health service guidelines to reduce perinatal transmission of HIV - Louisiana, Michigan, New Jersey and South Carolina, 1993, 1995 and 1996. MMWR Morb Mortal Wkly Rep. 1998;47:688-694.
8. Centers for Disease Control and Prevention. Prenatal discussion of HIV testing and maternal HIV testing - 14 states, 1996-1997. MMWR Morb Mortal Wkly Rep. 1999;48:401-404.
9. Walter EB, Lampe MA, Livingston E, Royce RA. How do North Carolina prenatal care provider's counsel and test pregnant women for HIV? N C Med J. 1998;59:105-109.
10. Lovvorn AE, Quinn SC, Jolly DH. HIV testing of pregnant women: a policy analysis. J Public Health Policy. 1997;18:401-432.
11. McNeeley DF, Laroche L, Bhutra S, Suarez E, Rao S, Rajegowda B. Newborn screening for human immunodeficiency virus infection in the Bronx, NY, and evolving public health policy. Am J Perinatol. 1999;16:503-507.
12. Mutcherson K, Rios E. Policy gone wrong: mandatory HIV testing of pregnant women and newborns. Presented at: The National Conference on Women and HIV/AIDS; June 1999; Los Angeles, Calif.
13. Jayaraman GC, Preiksaitis JK, Larke B. Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ. 2003;168:679-682.
14. MMWR Morb Mortal Wkly Rep. 2002;51:1010-1016.
15. Lindsay MK, Feng TI, Peterson HB, Slade BA, Willis S, Klein L. Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients. Obstet Gynecol. 1991;77:599-603.
16. Lindsay MK, Adefris W, Peterson HB, Williams H, Johnson J, Klein L. Determinants of acceptance of routine voluntary HIV testing in an inner-city prenatal population. Obstet Gynecol. 1991;78:678-680.
17. Joo E, Carmack A, Garcia-Bunuel E, Kelly CJ. Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women. Am J Public Health. 2000;90:273-276.
18. Grimes RM, Richards EP, Helfgott AW, Eriksen NL. Legal considerations in screening pregnant women for human immunodeficiency virus. Am J Obstet Gynecol. 1999;180:259-264.
19. Irwin KL, Valdiserri RO, Holmberg SD. The acceptability of voluntary HIV antibody testing in the United States: a decade of lessons learned. AIDS. 1996;10:1707-1717.
20. Royce RA, Walter EB, Fernancez MI, Wilson TE, Ickovics JR. Perinatal guidelines evaluation project. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health. 2001;91:727-733.
21. Ethier KA, Fox-Tierney R, Nicholas WC, Salisbury KM, Ickovics JR. Organizational predictors of prenatal HIV counseling and testing. Am J Public Health. 2000;90:1448-1451.
22. Webber MP, Schoenbaum EE, Bonuck KA. Correlates of voluntary HIV antibody testing reported by postpartum women. J Am Med Women's Assoc. 1997;52:89-92.
23. Mofenson LM, McIntyre JA. Advances and research directions in the prevention of mother-to-child HIV-1 transmission. Lancet. 2000;355:2237-2243.